AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2025
Dec 8, 2025
30870_dirs_2025-12-08_84252c18-ce58-4745-a01c-a117afde5f86.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-12-08
Reporting Person: Callos Andrew (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-08 | Common Stock | M | 1042 | $39.13 | Acquired | 51702 | Direct |
| 2025-12-08 | Common Stock | S | 1042 | $65.96 | Disposed | 50660 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-08 | Non-Qualified Stock Option (Right to Buy) | $39.13 | M | 1042 | Disposed | 2033-03-06 | Common Stock (1042) | Direct |
More from CYTOKINETICS INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18